Blueprint Medicines Ownership | Who Owns Blueprint Medicines?
Blueprint Medicines Ownership Summary
Blueprint Medicines is owned by 5.79% institutional investors, 0.87% insiders, and 93.35% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.84% of BPMC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.17% of its assets in Blueprint Medicines shares.
BPMC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Blueprint Medicines | 5.79% | 0.87% | 93.35% |
| Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 6.87M | 10.84% | $599.14M |
| Vanguard group | 6.77M | 10.69% | $590.91M |
| Blackrock | 6.65M | 10.58% | $716.45M |
| Price t rowe associates inc /md/ | 5.68M | 8.96% | $495.33M |
| Wellington management group llp | 4.28M | 6.75% | $373.42M |
| State street | 2.50M | 3.94% | $218.07M |
| Fmr | 2.25M | 3.55% | $196.04M |
| William blair investment management | 1.94M | 3.07% | $169.62M |
| Geode capital management | 1.49M | 2.35% | $130.00M |
| Macquarie group | 1.26M | 1.99% | $109.81M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Aquilo capital management | 83.93K | 13.32% | $7.43M |
| Ally bridge group (ny) | 55.89K | 4.18% | $4.87M |
| Dafna capital management | 152.26K | 3.82% | $13.48M |
| Orion investment | 108.67K | 3.78% | $9.48M |
| Rock springs capital management lp | 1.10M | 3.64% | $95.67M |
| Casdin capital | 326.38K | 2.36% | $28.89M |
| Integral health asset management | 275.00K | 2.04% | $23.99M |
| Stempoint capital lp | 61.93K | 1.75% | $5.48M |
| First turn management | 92.03K | 1.64% | $8.15M |
| Novo | 228.80K | 1.54% | $20.25M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avoro capital advisors | 1.19M | 1.46% | 1.19M |
| Norges bank | 711.16K | 0.01% | 711.16K |
| Eventide asset management | 862.28K | 1.37% | 513.58K |
| 1832 asset management | 502.65K | 0.04% | 502.40K |
| Braidwell lp | 439.97K | 1.37% | 439.97K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 2.25M | 0.01% | -2.27M |
| Lord, abbett | 335.04K | 0.09% | -843.15K |
| Morgan stanley | 421.26K | 0.00% | -637.43K |
| Man group | 103.92K | 0.02% | -414.70K |
| Driehaus capital management | - | - | -358.25K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Avoro capital advisors | 1.19M | 1.46% | 1.19M | $103.36M |
| Norges bank | 711.16K | 0.01% | 711.16K | $62.03M |
| Braidwell lp | 439.97K | 1.37% | 439.97K | $38.94M |
| Jennison associates | 360.21K | 0.02% | 360.21K | $31.42M |
| Sofinnova investments | 261.04K | 1.51% | 261.04K | $23.10M |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -4.00 |
| Financial gravity asset management | -4.00 |
| J.safra asset management | -5.00 |
| Rakuten securities | -5.00 |
| Innealta capital | -6.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 19 | -94.78% | 3,679,558 | -94.53% | 5 | 0.05% | 12 | -94.15% | 5 | -95.05% |
| Dec 31, 2024 | 362 | 5.23% | 67,270,926 | 3.92% | 106 | 1.02% | 202 | 2.02% | 102 | 21.43% |
| Sep 30, 2024 | 339 | 3.04% | 64,638,237 | -2.28% | 101 | 0.92% | 196 | 17.37% | 83 | -17.82% |
| Jun 30, 2024 | 329 | 7.17% | 66,148,228 | 1.60% | 105 | 0.94% | 167 | 8.44% | 101 | 9.78% |
| Mar 31, 2024 | 307 | 9.64% | 65,103,888 | 1.92% | 105 | 0.95% | 154 | 22.22% | 92 | -3.16% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.05M | 3.17% | 36.31K |
| Vanguard US Total Market Shares ETF | 2.00M | 3.13% | 1.81K |
| T. Rowe Price New Horizons | 2.00M | 3.13% | -27.01K |
| US Small-Cap Growth II Equity Comp | 2.00M | 3.13% | -54.30K |
| iShares Russell 2000 ETF | 1.63M | 2.52% | 798.00 |
| Vanguard Small Cap Index | 1.60M | 2.48% | 8.99K |
| T. Rowe Price Health Sciences | 1.54M | 2.41% | -80.02K |
| Vanguard Health Care Inv | 1.36M | 2.11% | -727.09K |
| SPDR® S&P Biotech ETF | 1.12M | 1.74% | 1.45K |
| Vanguard Institutional Extnd Mkt Idx Tr | 987.07K | 1.53% | 5.83K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 03, 2025 | Carter Percy H. | CHIEF SCIENTIFIC OFFICER | Sell | $309.21K |
| Jun 03, 2025 | Carter Percy H. | CHIEF SCIENTIFIC OFFICER | Sell | $30.82K |
| May 27, 2025 | Albers Jeffrey W. | - | Sell | $66.25K |
| May 27, 2025 | Albers Jeffrey W. | - | Sell | $439.44K |
| May 19, 2025 | Rossi Christina | CHIEF OPERATING OFFICER | Sell | $5.80K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 18 |
| 2025 Q1 | - | 32 |
| 2024 Q4 | - | 18 |
| 2024 Q3 | - | 6 |
| 2024 Q2 | - | 21 |
BPMC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools